13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0001012975-25-000233
Total Value
$123.6M
Positions
11
Other Managers
1
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | OCULIS HOLDING AG | OCSAW | 2,300,774 | $43.8M | 35.43% |
| 2 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,120,508 | $33.2M | 26.84% |
| 3 | VAXCYTE INC | PCVX | 710,734 | $26.8M | 21.72% |
| 4 | ZENAS BIOPHARMA INC | ZBIO | 736,645 | $5.8M | 4.71% |
| 5 | INOZYME PHARMA INC | 45790W108 | 4,494,851 | $4.1M | 3.31% |
| 6 | RECURSION PHARMACEUTICALS IN | RXRX | 595,518 | $3.2M | 2.55% |
| 7 | BIOAGE LABS INC | BIOA | 653,374 | $2.5M | 1.99% |
| 8 | RALLYBIO CORP | RLYB | 2,404,644 | $1.6M | 1.26% |
| 9 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $997,859 | 0.81% |
| 10 | IO BIOTECH INC | IOBT | 864,197 | $941,975 | 0.76% |
| 11 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $756,587 | 0.61% |